CIALIS is a substrate of and predominantly metabolized by CYP3A4. Experiments have revealed that medications that inhibit CYP3A4 can boost tadalafil exposure.No dose adjustment is warranted. The lowered publicity of tadalafil Using the coadministration of rifampin or other CYP3A4 inducers could be predicted to minimize the efficacy of CIALIS for af